Literature DB >> 9220940

Terfenadine therapy: can we justify the risks?

R Rangno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9220940      PMCID： PMC1227660     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?

Authors:  D A Flockhart
Journal:  J Clin Psychopharmacol       Date:  1996-04       Impact factor: 3.153

2.  Hay fever drug to become prescription only.

Authors:  J Wise
Journal:  BMJ       Date:  1997-05-03

3.  Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance.

Authors:  S E Rau; J R Bend; M O Arnold; L T Tran; J D Spence; D G Bailey
Journal:  Clin Pharmacol Ther       Date:  1997-04       Impact factor: 6.875

4.  Chlorpheniramine plasma concentration and histamine H1-receptor occupancy.

Authors:  S U Yasuda; A Wellstein; P Likhari; J T Barbey; R L Woosley
Journal:  Clin Pharmacol Ther       Date:  1995-08       Impact factor: 6.875

Review 5.  The pharmacology and use of H1-receptor-antagonist drugs.

Authors:  F E Simons; K J Simons
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245
  5 in total
  4 in total

1.  Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?

Authors:  Hua Rong Lu; An N Hermans; David J Gallacher
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  A lingering mistake.

Authors:  Jacques Weissenburger
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

3.  On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships.

Authors:  Christopher W McAleer; Amy Pointon; Christopher J Long; Rocky L Brighton; Benjamin D Wilkin; L Richard Bridges; Narasimham Narasimhan Sriram; Kristin Fabre; Robin McDougall; Victorine P Muse; Jerome T Mettetal; Abhishek Srivastava; Dominic Williams; Mark T Schnepper; Jeff L Roles; Michael L Shuler; James J Hickman; Lorna Ewart
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

Review 4.  Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications.

Authors:  F Peter Guengerich
Journal:  Biomol Ther (Seoul)       Date:  2022-01-01       Impact factor: 4.634
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.